GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 32 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $26,000 | – | 4,629 | +10186.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 45 | -99.9% | 0.00% | – |
| Q2 2019 | $237,000 | -11.2% | 32,300 | -1.5% | 0.00% | – |
| Q1 2019 | $267,000 | +16.6% | 32,800 | -2.4% | 0.00% | – |
| Q4 2018 | $229,000 | -42.5% | 33,600 | -53.1% | 0.00% | – |
| Q1 2018 | $398,000 | +61.8% | 71,585 | +165.6% | 0.00% | – |
| Q4 2017 | $246,000 | +969.6% | 26,949 | +418.2% | 0.00% | – |
| Q2 2016 | $23,000 | -20.7% | 5,200 | +65.7% | 0.00% | – |
| Q1 2015 | $29,000 | -85.1% | 3,139 | -84.3% | 0.00% | – |
| Q2 2014 | $194,000 | -15.3% | 20,000 | 0.0% | 0.00% | – |
| Q1 2014 | $229,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,878,508 | $12,830,000 | 1.68% |
| Knoll Capital Management, LLC | 210,000 | $1,434,000 | 1.63% |
| Vivo Capital, LLC | 971,337 | $6,634,000 | 0.85% |
| P.A.W. CAPITAL CORP | 90,000 | $615,000 | 0.77% |
| 683 Capital Management, LLC | 1,350,000 | $9,221,000 | 0.56% |
| Ibex Investors LLC | 500,000 | $3,415,000 | 0.56% |
| MEITAV INVESTMENT HOUSE LTD | 653,667 | $4,465,000 | 0.28% |
| FIRST MIDWEST BANK TRUST DIVISION | 214,872 | $1,468,000 | 0.22% |
| Nantahala Capital Management | 834,401 | $5,699,000 | 0.18% |
| PREMIER ASSET MANAGEMENT LLC | 73,950 | $505,000 | 0.14% |